Allscripts Healthcare Solutions Inc. [MDRX] Chief Financial Officer makes an insider purchase of 7,000 shares worth 0.12 million.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Allscripts Healthcare Solutions Inc. shares valued at $116,331 were sold by Jones Leah on Sep 13. At $16.62 per share, Jones Leah sold 7,000 shares. The insider’s holdings dropped to 98,362 shares worth approximately $1.64 million following the completion of this transaction.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Also, Jones Leah sold 3,921 shares, netting a total of over 69,206 in proceeds. Following the sale of shares at $17.65 each, the insider now holds 109,055 shares.

Before that, Poulton Richard J. had sold 10,000 shares from its account. In a trade valued at $174,375, the CEO traded Allscripts Healthcare Solutions Inc. shares for $17.44 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $12.23 million.

As published in their initiating research note from KeyBanc Capital Markets on September 16, 2022, Allscripts Healthcare Solutions Inc. [MDRX] has been a Sector weight. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in mid July. As of March 04, 2022, Deutsche Bank has increased its “Hold” rating to a “Buy” for MDRX. Earlier on January 25, 2022, SVB Leerink upgraded its rating. Their new recommendation was “an Outperform” for MDRX stock which previously was a “a Mkt perform”.

Analyzing MDRX’s Price Performance

On Thursday, Allscripts Healthcare Solutions Inc. [NASDAQ: MDRX] rose 0.85% to $16.70. The stock’s lowest price that day was $16.26, but it reached a high of $16.815 in the same session. During the last five days, there has been a surge of approximately 0.18%. Over the course of the year, Allscripts Healthcare Solutions Inc. shares have dropped approximately -9.49%. Shares of the company reached a 52-week high of $23.25 on 04/21/22 and a 52-week low of $13.99 on 07/14/22. A 50-day SMA is recorded $16.45, while a 200-day SMA reached $18.40. Nevertheless, trading volume fell to 2.15 million shares from 1.03 million shares the previous day.

Support And Resistance Levels for Allscripts Healthcare Solutions Inc. (MDRX)

According to the 24-hour chart, there is a support level at 16.37, which, if violated, would cause prices to drop to 16.04. In the upper region, resistance lies at 16.92. The next price resistance is at 17.15. RSI (Relative Strength Index) is 49.82 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.03, which suggests the price will decrease in the coming days. Percent R is at 48.78%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Is Allscripts Healthcare Solutions Inc. subject to short interest?

Stocks of Allscripts Healthcare Solutions Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -2.07 million shares to 10.98 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 13.05 million shares. A decline of -18.85% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.84 of the overall float, the days-to-cover ratio (short ratio) decline to 6.84.

Which companies own the most shares of Allscripts Healthcare Solutions Inc. (MDRX)?

According to BlackRock Fund Advisors filings, the company currently owns 18,189,259 shares, which is about 16.42% of the total MDRX shares outstanding. The investor’s shares have plunged by -951,497 from its previous 13-F filing of 19140756.0 shares. With the completion of the buy transaction, The Vanguard Group, Inc.’s stake is now worth $236,978,402. Dimensional Fund Advisors LP reduced a -3.19% interest valued at $159.33 million while Fisher Asset Management LLC sold a -98,372 stake. A total of -194,215 shares of Allscripts Healthcare Solutions Inc. were sold by SSgA Funds Management, Inc. during the quarter, and -624,828 were sold by D. E. Shaw & Co. LP. In its current portfolio, Fuller & Thaler Asset Management, holds 2,841,368 shares valued at $48.3 million.

In terms of Allscripts Healthcare Solutions Inc. share price expectations, FactSet research, analysts set an average price target of $22.00 in the next 12 months, up nearly 32.85% from the previous closing price of $16.56. Analysts anticipate Allscripts Healthcare Solutions Inc. stock to reach $26.00 by 2022, with the lowest price target being $18.00. In spite of this, 10 analysts ranked Allscripts Healthcare Solutions Inc. stock as an Overweight at the end of 2022. On April 29, 2021, JP Morgan assigned a price target of “an Underweight” to the stock and resumed coverage with a $15.

LEAVE A REPLY

Please enter your comment!
Please enter your name here